TG Therapeutics | TGTX - Bruttoergebnis Vom Umsatz

Aktienkurs
30.07
Täglich Wechseln
-0.29 -0.96%
Monatlich
-1.64%
Jährlich
-30.05%
Q1 Prognose
29.17




Bruttoergebnis Vom Umsatz Veränderung Datum
AbbVie USD 10.47B 605M 2025-09
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.48B 307M 2025-09
Ardelyx USD 114.37M 8.02M 2025-12
Arrowhead Research USD 256.47M 228.7M 2025-09
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.65B 34.6M 2025-12
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Curis USD -7.72M 140K 2024-06
Gilead Sciences USD 6.31B 106M 2025-12
Infinity Pharmaceuticals USD 231K 59K 2023-06
J&J USD 16.6B 118M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Novartis USD 10.25B 570M 2025-12
Novavax USD 125.04M 76.09M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
TG Therapeutics USD 154.43M 20.81M 2025-12
Verastem USD 545K 543K 2021-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12